INR:9057. marathonbet et Bristol-Myers Squibb's deucravacitinib significantly improves signs and symptoms of psoriatic arthritis Opdivo + Cabometyx combination for ...
Bristol Myers on Monday said the two Phase 3 studies met their primary endpoint, with a significantly greater proportion of Sotyktu-treated patients achieving at least a 20% improvement in signs and ...